The Mexican Health Authority (COFEPRIS) has recently signed joint declarations with Germany and Denmark to promote and strengthen the cooperation and exchange of good practices regarding health risks.
Regarding the agreement with the Danish Health Authority (DMA), the Federal Commissioner of COFEPRIS, Julio Sánchez y Tépoz, stated that "the agreement will allow the exchange of information in the field of healthcare products, including drugs, raw materials for pharmaceutical use, biological products and medical devices."
COFEPRIS and the German Health Authority (BfArM) agreed about the exchange of information regarding the drugs and medical devices regulations, including policies, guidelines, practices, laboratory analysis, marketing authorizations and drug surveillance.
Originally published on 11 May 2016
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.